AnalystsDavid NierengartenDavid Nierengarten's Stock Forecasts
AnalystsDavid Nierengarten
Analyst Ranking
Top 3%
#77 out of 3772 analysts
Average Return
+28.12%
Win Rate
51%30 out of 59
Risk vs Reward
Poor
Good
David Nierengarten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
ANAPTYSBIO INCANAB | +405.93% | $23.10 | $116.87 | 2017-03-09 - 2018-03-09 | Buy |
BEAM THERAPEUTICS INCBEAM | +300.96% | $23.02 | $92.30 | 2020-03-02 - 2021-03-02 | Buy |
FATE THERAPEUTICS INCFATE | +291.11% | $22.94 | $89.72 | 2020-04-03 - 2021-02-26 | Buy |
KARYOPHARM THERAPEUTICS INCKPTI | +287.27% | $4.40 | $17.04 | 2019-02-27 - 2020-01-17 | Buy |
ENDOCYTE INCECYT | +188.44% | $5.88 | $16.96 | 2017-10-03 - 2018-10-03 | Buy |
David Nierengarten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
TURNING POINT THERAPEUTICS INCTPTX | 1 | Hold | $76.00 | +1.10% | Downgrades | 23 days ago |
SPRINGWORKS THERAPEUTICS INCSWTX | 1 | Buy | $50.00 | +94.93% | Maintains | a month ago |
INOZYME PHARMA INCINZY | 2 | Buy | $25.00 | +392.13% | Maintains | 3 months ago |
CODIAK BIOSCIENCES INCCDAK | 1 | Buy | $24.00 | +516.97% | Maintains | 4 months ago |
FATE THERAPEUTICS INCFATE | 6 | Buy | $74.00 | +176.12% | Upgrades | 6 months ago |
2SEVENTY BIO INCTSVT | 1 | Buy | $40.00 | +191.12% | Initiates Coverage On | 8 months ago |
THESEUS PHARMACEUTICALS INCTHRX | 1 | Buy | $24.00 | +298.67% | Initiates Coverage On | 8 months ago |
TCR2 THERAPEUTICS INCTCRR | 1 | Hold | $11.00 | +284.62% | Downgrades | 9 months ago |
ARGENX SEARGX | 7 | Buy | $362.00 | -0.64% | Maintains | a year ago |
BEAM THERAPEUTICS INCBEAM | 2 | Buy | $149.00 | +250.51% | Maintains | a year ago |
INTELLIA THERAPEUTICS INCNTLA | 3 | Hold | $87.00 | +62.89% | Maintains | a year ago |
NOVOCURE LTDNVCR | 3 | Sell | $154.00 | N/A | Downgrades | a year ago |
CHIMERIX INCCMRX | 1 | Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
ANAPTYSBIO INCANAB | 4 | Hold | N/A | N/A | Downgrades | a year ago |
NUVATION BIO INCNUVB | 1 | Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
MYOKARDIA INCMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 2 years ago |
FREELINE THERAPEUTICS HOLDINGS PLCFRLN | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
FUSION PHARMACEUTICALS INCFUSN | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
STEMLINE THERAPEUTICS INCSTML | 3 | Hold | $12.50 | N/A | Downgrades | 2 years ago |
G1 THERAPEUTICS INCGTHX | 2 | Buy | $55.00 | N/A | Maintains | 2 years ago |
KARYOPHARM THERAPEUTICS INCKPTI | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
IVERIC BIO INCISEE | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 2 years ago |
XENCOR INCXNCR | 2 | Buy | $44.00 | N/A | Maintains | 4 years ago |
TESARO INCTSRO | 3 | Hold | $75.00 | N/A | Downgrades | 4 years ago |
SPARK THERAPEUTICS INCONCE | 2 | Hold | $40.00 | N/A | Upgrades | 4 years ago |
ULTRAGENYX PHARMACEUTICAL INCRARE | 6 | Buy | $88.00 | N/A | Maintains | 4 years ago |
SUTRO BIOPHARMA INCSTRO | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
AUDENTES THERAPEUTICS INCBOLD | 1 | Buy | $52.00 | N/A | Maintains | 4 years ago |
FENNEC PHARMACEUTICALS INCFENC | 2 | Buy | $16.00 | N/A | Maintains | 4 years ago |
ENDOCYTE INCECYT | 3 | Buy | $21.00 | N/A | Maintains | 4 years ago |
VOYAGER THERAPEUTICS INCVYGR | 2 | Buy | N/A | N/A | Upgrades | 4 years ago |
BLUEPRINT MEDICINES CORPBPMC | 1 | Buy | $106.00 | N/A | Maintains | 4 years ago |
SYROS PHARMACEUTICALS INCSYRS | 1 | Buy | $13.00 | N/A | Maintains | 4 years ago |
PROTHENA CORP PUBLIC LTD COPRTA | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
KITE PHARMA INCKITE | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
JUNO THERAPEUTICS INCJUNO | 1 | Buy | N/A | N/A | Upgrades | 5 years ago |
CLEMENTIA PHARMACEUTICALS INCCMTA | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
NOVAN INCNOVN | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.